458
Participants
Start Date
September 30, 2011
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
Blood sampling
Subjects with pre-established diagnosis of IGHD and TS and were treated with r-hGH therapy for 1 year, will be observed in this retrospective cohort study wherein blood sampling will performed for genotyping of the various genetic markers along with collection of retrospective data relative to the r-hGH treatment.
Hospital de Niños Ricardo Gutiérrez, Buenos Aires
Hospital de Pediatria Garrahan, Buenos Aires
Hospital de Niños de la Santisima Trinidad, Córdoba
University of Calgary - Alberta Children's Hospital, Calgary
CHU Sainte Justine Montréal, Montreal
Centre Hospitalier Universitaire de Sherbrooke - Fleurimont, Sherbrooke
British Columbia Children's Hospital, Vancouver
Fakultní nemocnice Brno, Brno
University Hospital Hradec Kralove, Hradec Králové
Faculty Hospital, Olomouc
University Hospital Praha Motol, Prague
Centre d'Endocrinologie Pédiatrique, Bordeaux
CHU Bordeaux - Hopital pédiatrique Pellegrin, Bordeaux
Hôpital Femme-Mère-Enfant, Bron
University of Cologne Children's Hospital, Cologne
University Children's Hospital, München
University of Bari Aldo Moro, Bari
Ospedale Microcitemico di Cagliari, Cagliari
Centro di Endocrinologia e Diabetologia Pediatrica, Catania
Istituto Giannina Gaslini - Clinica Pediatrica, Genova
Hospital 12 de Octubre, Madrid
Hospital Infantil Universitario Niño Jesús, Madrid
Hospital Universitario Gregorio Maran, Madrid
Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela
Hospital Miguel Servet, Zaragoza
Queen Silvia Children's Hospital, Gothenburg
Faculty of Health Sciences, Linkping University, Linköping
Karolinska University Hospital Campus Solna, Stockholm
Birmingham Children's Hospital, Birmingham
Royal Manchester Children's Hospital, Manchester
Sheffield Children's Hospital, Sheffield
Merck Serono S.A., Geneva
INDUSTRY
Merck KGaA, Darmstadt, Germany
INDUSTRY